390 related articles for article (PubMed ID: 23659563)
41. Antimicrobial selection and its impact on the incidence of Clostridium difficile-associated diarrhea.
Montoya M; Detorres O
J Pharm Pract; 2013 Oct; 26(5):483-7. PubMed ID: 23940122
[TBL] [Abstract][Full Text] [Related]
42. Fidaxomicin (OPT-80) for the treatment of Clostridium difficile infection.
Miller M
Expert Opin Pharmacother; 2010 Jun; 11(9):1569-78. PubMed ID: 20446864
[TBL] [Abstract][Full Text] [Related]
43. Preventing downstream Clostridium difficile infections with upstream antibiotic management.
Malkan AD; Scholand SJ
Med Hypotheses; 2012 Jan; 78(1):136-7. PubMed ID: 22079651
[TBL] [Abstract][Full Text] [Related]
44. Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship.
Harpe SE; Inocencio TJ; Pakyz AL; Oinonen MJ; Polk RE
Pharmacotherapy; 2012 Aug; 32(8):744-54. PubMed ID: 23307522
[TBL] [Abstract][Full Text] [Related]
45. Diagnosis and management of Clostridium difficile infection.
Korman TM
Semin Respir Crit Care Med; 2015 Feb; 36(1):31-43. PubMed ID: 25643269
[TBL] [Abstract][Full Text] [Related]
46. Detection, treatment, and prevention of Clostridium difficile infection.
McCollum DL; Rodriguez JM
Clin Gastroenterol Hepatol; 2012 Jun; 10(6):581-92. PubMed ID: 22433924
[TBL] [Abstract][Full Text] [Related]
47. An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings.
Aldeyab MA; Kearney MP; Scott MG; Aldiab MA; Alahmadi YM; Darwish Elhajji FW; Magee FA; McElnay JC
J Antimicrob Chemother; 2012 Dec; 67(12):2988-96. PubMed ID: 22899806
[TBL] [Abstract][Full Text] [Related]
48. Fidaxomicin for the treatment of Clostridium difficile infections.
Whitman CB; Czosnowski QA
Ann Pharmacother; 2012 Feb; 46(2):219-28. PubMed ID: 22318930
[TBL] [Abstract][Full Text] [Related]
49. Changes in laboratory and clinical workload for Clostridium difficile infection from 2003 to 2007 in hospitals in Edinburgh.
Reddy S; Taori S; Poxton IR
Clin Microbiol Infect; 2010 Apr; 16(4):340-6. PubMed ID: 20222891
[TBL] [Abstract][Full Text] [Related]
50. Fidaxomicin: the newest addition to the armamentarium against Clostridium difficile infections.
Lancaster JW; Matthews SJ
Clin Ther; 2012 Jan; 34(1):1-13. PubMed ID: 22284993
[TBL] [Abstract][Full Text] [Related]
51. Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections.
McFarland LV; Ozen M; Dinleyici EC; Goh S
World J Gastroenterol; 2016 Mar; 22(11):3078-104. PubMed ID: 27003987
[TBL] [Abstract][Full Text] [Related]
52. Clostridium difficile infection and inflammatory bowel disease.
Reddy SS; Brandt LJ
J Clin Gastroenterol; 2013 Sep; 47(8):666-71. PubMed ID: 23507767
[TBL] [Abstract][Full Text] [Related]
53. Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics.
Hensgens MP; Goorhuis A; Dekkers OM; Kuijper EJ
J Antimicrob Chemother; 2012 Mar; 67(3):742-8. PubMed ID: 22146873
[TBL] [Abstract][Full Text] [Related]
54. An antimicrobial stewardship program's real-world experience with fidaxomicin for treatment of Clostridium difficile infection: a case series.
Vargo CA; Bauer KA; Mangino JE; Johnston JE; Goff DA
Pharmacotherapy; 2014 Sep; 34(9):901-9. PubMed ID: 24898525
[TBL] [Abstract][Full Text] [Related]
55. [Clostridium difficile infections, specific issues in the elderly].
Castrillon BO; Harbarth S; Prendki V
Rev Med Suisse; 2013 Nov; 9(405):2044-8. PubMed ID: 24308141
[TBL] [Abstract][Full Text] [Related]
56. Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome.
Willems L; Porcher R; Lafaurie M; Casin I; Robin M; Xhaard A; Andreoli AL; Rodriguez-Otero P; Dhedin N; Socié G; Ribaud P; Peffault de Latour R
Biol Blood Marrow Transplant; 2012 Aug; 18(8):1295-301. PubMed ID: 22387347
[TBL] [Abstract][Full Text] [Related]
57. Recent trends in the epidemiology and treatment of C. difficile infection in children.
Sammons JS; Toltzis P
Curr Opin Pediatr; 2013 Feb; 25(1):116-21. PubMed ID: 23241874
[TBL] [Abstract][Full Text] [Related]
58. Real-time polymerase chain reaction testing for Clostridium difficile reduces isolation time and improves patient management in a small community hospital.
Catanzaro M; Cirone J
Am J Infect Control; 2012 Sep; 40(7):663-6. PubMed ID: 22153847
[TBL] [Abstract][Full Text] [Related]
59. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection.
Debast SB; Bauer MP; Kuijper EJ;
Clin Microbiol Infect; 2014 Mar; 20 Suppl 2():1-26. PubMed ID: 24118601
[TBL] [Abstract][Full Text] [Related]
60. Clostridium difficile Infection in Children.
Alvarez AM; Rathore MH
Adv Pediatr; 2019 Aug; 66():263-280. PubMed ID: 31230698
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
